Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verinurad and Allopurinol Interaction in Gout
NCT02279641Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of verinurad in gout (2 arms), sponsored by Ardea Biosciences, Inc. Primary endpoints: Maximum Observed Plasma Concentration at 22 days, Time of Occurrence of Maximum Observed Concentration at 22 days and 6 more. Started Nov 2014; status: completed.
02
Drugs
verinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT02279641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279641.